Blind Assessment of the Concordance Between the Administered Treatment and the Recommendations of a Medical Algorithm Decision Support Software in Systolic Heart Failure

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02900547

Acronym

PREMEDIC

Enrollment

300

Registered

2016-09-14

Start date

2015-07-31

Completion date

2018-06-30

Last updated

2016-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearth Failure, Systolic

Keywords

Systolic Heart Failure, medical algorithm decision support system

Brief summary

The PREMEDIC is a prospective, observational study. Patients hospitalized for Systolic Heart Failure will be enrolled and health data will be collected at hospital admission and during hospital stay. No data will be collected before detailed information is given to the patient and a non-opposition is obtained. The aim of this observational and prospective study is to evaluate the concordance actual patient management during the in hospital treatment of heart failure and the therapeutic proposals from a medical algorithmic decision support software.

Detailed description

Main Objective: The aim of this observational and prospective study is to evaluate retrospectively the concordance between the actual systolic heart failure patient management during the inhospital treatment of heart failure (as recorded from the usual healthcare data collected) and the therapeutic proposals from a medical algorithmic decision support software. Secondary Objectives: To study the evolution of biological, hepatic and cardiopulmonary ultrasound usual markers in hospitalization, in connection with the duration of hospitalization and drug administered.

Interventions

OTHERPatients with systolic heart failure

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years old or over * Patients hospitalized for decompensated systolic heart failure * Patients informed

Exclusion criteria

* Patients unwillingness to participate

Design outcomes

Primary

Measure	Time frame
Retrospective evaluation of the concordance between the drug therapy actually used and the therapeutic algorithm's proposals	an average of 7 days

Secondary

Measure	Time frame
Duration of hospitalization (number of days)	an average of 7 days
Weight evolution (Kilograms)	an average of 7 days

Countries

France

Contacts

Primary ContactPatrick ROSSIGNOL, Professor

p.rossignol@chru-nancy.fr0033383157322

Backup ContactNicolas GIRERD

n.girerd@chru-nancy.fr0033383157322

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026